Management of Febrile Episodes in Neutropenic Patients: Defining the Role of Meropenem
Year of publication: |
1999
|
---|---|
Authors: | Lamb, Harriet M. ; Goa, Karen L. |
Published in: |
Disease Management and Health Outcomes. - Springer Healthcare | Adis, ISSN 1173-8790. - Vol. 5.1999, 2, p. 101-115
|
Publisher: |
Springer Healthcare | Adis |
Subject: | Reviews-on-treatment | Immunocompromised-infections | Peptide-antibiotics | Ceftazidime | Amikacin | Imipenem.cilastatin | Meropenem | Pharmacoeconomics | Neutropenia | Fever | Cancer | Antibacterials | Economic-implications |
Extent: | application/pdf text/html |
---|---|
Type of publication: | Article |
Classification: | C - Mathematical and Quantitative Methods ; D - Microeconomics ; I - Health, Education, and Welfare ; Z - Other Special Topics ; I1 - Health ; I19 - Health. Other ; I18 - Government Policy; Regulation; Public Health ; I11 - Analysis of Health Care Markets |
Source: |
-
Bucaneve, Giampaolo, (1999)
-
Meropenem: A Pharmacoeconomic Review of its Use in Serious Infections
Holliday, Stephen M., (1998)
-
Dranitsaris, George, (1999)
- More ...
-
Management of Patients with Cystic Fibrosis: Defining the Role of Inhaled Tobramycin
Lamb, Harriet M., (1999)
-
Rivastigmine: A Pharmacoeconomic Review of its Use in Alzheimer's Disease
Lamb, Harriet M., (2001)
-
Management of Community-Acquired Pneumonia: The Role of Clarithromycin
Barman Balfour, Julia A., (1999)
- More ...